Search for: "NOVO NORDISK PHARMACEUTICALS, INC."
Results 41 - 60
of 88
Sorted by Relevance
|
Sort by Date
15 Apr 2010, 7:04 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide)… [read post]
25 Jan 2022, 3:11 pm
There have already been several significant settlements that appear positioned for court approval in 2022, including Twitter ($809.5 million); Teva Pharmaceutical Industries ($420 million); Luckin Coffee ($175 million); Granite Construction ($129 million); Novo Nordisk A/S ($100 million); Stamps.com ($100 million) and NCI Building Systems, Inc. ($100 million). [read post]
4 Jan 2013, 7:03 am
Novo Nordisk A/S, 132 S.Ct. 1670 (2012). 6. [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
27 May 2011, 8:56 am
Novo Nordisk A/S . [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
11 Mar 2015, 9:40 am
Novo Nordisk A/S, 132 S.Ct. 1670 (2012) (forcing correction of Orange Book listings) KSR has actually rocketed to the position of most-cited Supreme Court patent case of all time followed by Markman (1996); U.S. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
27 May 2010, 3:20 am
(Patent Docs) PrandiMet (Repaglinide and Metformin) – US: Infringement of patent following Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
22 Oct 2015, 8:42 am
IMS Health, Inc., 131 S. [read post]
30 Apr 2012, 8:03 am
Novo Nordisk A/S Martel v. [read post]
9 Mar 2022, 2:06 pm
The largest 2021 settlements included one settlement in excess of $1 billion (the $1.21 billion settlement in the Valeant Pharmaceuticals International case) and four in excess of $100 million (Snap, Inc.: $187.5 million; DaVita, Inc.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
23 Dec 2011, 6:30 am
Novo Nordisk A/S, and the Court will begin the new year with Kappos v. [read post]
24 Mar 2011, 12:53 pm
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
